{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T09:27:26Z","timestamp":1794302846373,"version":"4.9.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ajo.2026.08.045","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:48:12Z","timestamp":1788364092000},"page":"371-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["LYNX-1: A Phase 3 Study of 0.75% Phentolamine Ophthalmic Solution in Subjects With Dim Light Vision Disturbances"],"prefix":"10.1016","volume":"292","author":[{"given":"JAY S.","family":"PEPOSE","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"STEPHEN","family":"MONTAQUILA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DAVID","family":"WIRTA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MITCHELL","family":"BRIGELL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KONSTANTINOS","family":"CHARIZANIS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ajo.2026.08.045_bib0001","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0039-6257(02)00350-8","article-title":"Night vision disturbances after corneal refractive surgery","volume":"47","author":"Fan-Paul","year":"2002","journal-title":"Surv Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2026.08.045_bib0002","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1136\/bjo.2006.110874","article-title":"Night vision disturbances after successful LASIK surgery","volume":"91","author":"Villa","year":"2007","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2026.08.045_bib0003","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00055735-200408000-00009","article-title":"Quality of vision and patient satisfaction after LASIK","volume":"15","author":"Hammond","year":"2004","journal-title":"Curr Opin Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2026.08.045_bib0004","doi-asserted-by":"crossref","DOI":"10.3928\/1081-597X-20031101-13","article-title":"Correlation of aberrations with visual symptoms using wavefront analysis in eyes after laser in situ keratomileusis","volume":"19","author":"Chalita","year":"2003","journal-title":"J Refract Surg"},{"issue":"3","key":"10.1016\/j.ajo.2026.08.045_bib0005","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ophtha.2003.06.022","article-title":"Wavefront analysis in post-LASIK eyes and its correlation with visual symptoms, refraction, and topography","volume":"111","author":"Chalita","year":"2004","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2026.08.045_bib0006","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jcrs.2004.12.036","article-title":"Night vision disturbance","volume":"31","author":"Rosen","year":"2005","journal-title":"J Cataract Refract Surg"},{"issue":"11","key":"10.1016\/j.ajo.2026.08.045_bib0007","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1097\/j.jcrs.0000000000000307","article-title":"Surgical management of positive dysphotopsia: U.S. perspective","volume":"46","author":"Masket","year":"2020","journal-title":"J Cataract Refract Surg"},{"issue":"1","key":"10.1016\/j.ajo.2026.08.045_bib0008","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/opo.12420","article-title":"Reducing starbursts in highly aberrated eyes with pupil miosis","volume":"38","author":"Xu","year":"2018","journal-title":"Ophthalmic Physiol Opt"},{"issue":"3","key":"10.1016\/j.ajo.2026.08.045_bib0009","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1167\/iovs.14-15414","article-title":"Ultrasound-based quantification of vitreous floaters correlates with contrast sensitivity and quality of life","volume":"56","author":"Mamou","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.ajo.2026.08.045_bib0010","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jcrs.2008.01.028","article-title":"Efficacy of brimonidine tartrate 0.2% ophthalmic solution in reducing halos after laser in situ keratomileusis","volume":"34","author":"Lee","year":"2008","journal-title":"J Cataract Refract Surg"},{"issue":"9","key":"10.1016\/j.ajo.2026.08.045_bib0011","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.jcrs.2008.05.029","article-title":"Effect of brimonidine tartrate 0.15% on night-vision difficulty and contrast testing after refractive surgery","volume":"34","author":"Edwards","year":"2008","journal-title":"J Cataract Refract Surg"},{"issue":"1","key":"10.1016\/j.ajo.2026.08.045_bib0012","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ajo.2004.02.017","article-title":"The effect of daily use of brimonidine tartrate on the dark-adapted pupil diameter","volume":"138","author":"Brown","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2026.08.045_bib0013","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jcrs.2006.01.024","article-title":"Severe photic phenomenon","volume":"32","author":"Ernest","year":"2006","journal-title":"J Cataract Refract Surg"},{"issue":"9","key":"10.1016\/j.ajo.2026.08.045_bib0014","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.jcrs.2005.02.042","article-title":"Pharmacological management of night vision disturbances after refractive surgery: results of a randomized clinical trial","volume":"31","author":"Randazzo","year":"2005","journal-title":"J Cataract Refract Surg"},{"issue":"11","key":"10.1016\/j.ajo.2026.08.045_bib0015","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/OPX.0000000000000963","article-title":"Effect of target luminance on optimum pupil diameter for presbyopic eyes","volume":"93","author":"Xu","year":"2016","journal-title":"Optom Vis Sci"},{"issue":"4","key":"10.1016\/j.ajo.2026.08.045_bib0016","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0039-6257(77)90114-X","article-title":"Quantification of the pinhole effect","volume":"21","author":"Miller","year":"1977","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2026.08.045_bib0017","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/jamaophthalmol.2022.0059","article-title":"Safety and efficacy of AGN-190584 in individuals with presbyopia: the GEMINI 1 phase 3 randomized clinical trial","volume":"140","author":"Waring","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2026.08.045_bib0018","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1080\/08164622.2023.2279189","article-title":"Impact of presbyopia treatment pilocarpine hydrochloride 1.25% on night-driving performance","volume":"107","author":"Waring","year":"2024","journal-title":"Clin Exp Optom"},{"issue":"1","key":"10.1016\/j.ajo.2026.08.045_bib0019","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/ICB.0000000000001309","article-title":"Rhegmatogenous retinal detachment after initiation of pilocarpine hydrochloride ophthalmic solution 1.25% for treatment of presbyopia","volume":"18","author":"Eton","year":"2024","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.ajo.2026.08.045_bib0020","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ajo.2022.05.011","article-title":"Retinal detachments associated with topical pilocarpine use for presbyopia","volume":"242","author":"Al-Khersan","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2026.08.045_bib0021","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3928\/23258160-20220629-01","article-title":"Vitreofoveal traction associated with pilocarpine for presbyopia","volume":"53","author":"Amarikwa","year":"2022","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"1","key":"10.1016\/j.ajo.2026.08.045_bib0022","doi-asserted-by":"crossref","DOI":"10.1186\/s12886-022-02621-6","article-title":"A randomized phase 2 clinical trial of phentolamine mesylate eye drops in patients with severe night vision disturbances","volume":"22","author":"Pepose","year":"2022","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.08.045_bib0023","first-page":"116","article-title":"Comparison of the repeatability and reproducibility of the OPD-scan III and iTrace aberrometers","volume":"15","author":"Wan","year":"2022","journal-title":"Int J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2026.08.045_bib0024","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/S0886-3350(03)00334-1","article-title":"Interaction between aberrations to improve or reduce visual performance","volume":"29","author":"Applegate","year":"2003","journal-title":"J Cataract Refract Surg"},{"issue":"9","key":"10.1016\/j.ajo.2026.08.045_bib0025","first-page":"1399","article-title":"How to report number needed to treat and its confidence interval?","volume":"32","author":"Varner","year":"2006","journal-title":"J Cataract Refract Surg"},{"issue":"5","key":"10.1016\/j.ajo.2026.08.045_bib0026","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00417-014-2876-z","article-title":"Repeatability of mesopic visual acuity measurements using high- and low-contrast ETDRS letter charts","volume":"253","author":"Barrio","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2026.08.045_bib0027","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00417-011-1675-z","article-title":"The dynamics of practice effects in an optotype acuity task","volume":"249","author":"Heinrich","year":"2011","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2026.08.045_bib0028","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/opo.12829","article-title":"Repeatability of an automated ETDRS contrast threshold measurement","volume":"41","author":"Pang","year":"2021","journal-title":"Ophthalmic Physiol Opt"},{"issue":"18","key":"10.1016\/j.ajo.2026.08.045_bib0029","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.jacc.2016.07.775","article-title":"Regression to the mean in SYMPLICITY HTN-3: implications for design and reporting of future trials","volume":"68","author":"Pocock","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.ajo.2026.08.045_bib0030","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1111\/epi.17730","article-title":"Quantifying and controlling the impact of regression to the mean on randomized controlled trials in epilepsy","volume":"64","author":"Goldenholz","year":"2023","journal-title":"Epilepsia"},{"issue":"15","key":"10.1016\/j.ajo.2026.08.045_bib0031","doi-asserted-by":"crossref","first-page":"7876","DOI":"10.3390\/ijerph18157876","article-title":"Minimum detectable change of visual acuity measurements using ETDRS charts","volume":"18","author":"S\u00e1nchez-Gonz\u00e1lez","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.ajo.2026.08.045_bib0032","doi-asserted-by":"crossref","DOI":"10.1186\/s12886-020-1331-7","article-title":"Association of photopic and mesopic contrast sensitivity in older drivers with risk of motor vehicle collision using naturalistic driving data","volume":"20","author":"Owsley","year":"2020","journal-title":"BMC Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2026.08.045_bib0033","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1177\/001872088502700602","article-title":"Contrast sensitivity predicts age-related differences in highway-sign discriminability","volume":"27","author":"Evans","year":"1985","journal-title":"Hum Factors"},{"issue":"10","key":"10.1016\/j.ajo.2026.08.045_bib0034","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/bjo.71.10.791","article-title":"Contrast sensitivity, acuity, and the perception of \"real-world\" targets","volume":"71","author":"Owsley","year":"1987","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.08.045_bib0035","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s003470050234","article-title":"Reduced visual capacity increases the risk of accidents in street traffic","volume":"95","author":"Lachenmayr","year":"1998","journal-title":"Ophthalmologe"},{"issue":"2","key":"10.1016\/j.ajo.2026.08.045_bib0036","first-page":"86","article-title":"Visual acuity and traffic accidents","volume":"185","author":"von Hebenstreit","year":"1984","journal-title":"Klin Monbl Augenheilkd"},{"issue":"11","key":"10.1016\/j.ajo.2026.08.045_bib0037","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1167\/iovs.10-5341","article-title":"The development of an instrument to measure quality of vision: the quality of vision (QoV) questionnaire","volume":"51","author":"McAlinden","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ajo.2026.08.045_bib0038","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/opo.12307","article-title":"Development and validation of a vision and night driving questionnaire","volume":"36","author":"Kimlin","year":"2016","journal-title":"Ophthalmic Physiol Opt"},{"issue":"3","key":"10.1016\/j.ajo.2026.08.045_bib0039","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/ICO.0b013e318033dbf0","article-title":"Outcomes of LASIK for myopia with FDA-approved lasers","volume":"26","author":"Bailey","year":"2007","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.ajo.2026.08.045_bib0040","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.ophtha.2008.12.038","article-title":"Comparison of night driving performance after wavefront-guided and conventional LASIK for moderate myopia","volume":"116","author":"Schallhorn","year":"2009","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ajo.2026.08.045_bib0041","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.jcrs.2005.08.022","article-title":"Functional outcomes and patient satisfaction after laser in situ keratomileusis for correction of myopia","volume":"31","author":"Tahzib","year":"2005","journal-title":"J Cataract Refract Surg"},{"issue":"5","key":"10.1016\/j.ajo.2026.08.045_bib0042","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0886-3350(01)00844-6","article-title":"Patient outcomes of refractive surgery: the refractive status and vision profile","volume":"27","author":"Schein","year":"2001","journal-title":"J Cataract Refract Surg"},{"issue":"11","key":"10.1016\/j.ajo.2026.08.045_bib0043","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-232473","article-title":"Persistently poor vision in dim illumination after implantation of XtraFocus small-aperture IOL (Morcher)","volume":"12","author":"Agarwal","year":"2019","journal-title":"BMJ Case Rep"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426005003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426005003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T09:03:33Z","timestamp":1794301413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939426005003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":43,"alternative-id":["S0002939426005003"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2026.08.045","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LYNX-1: A Phase 3 Study of 0.75% Phentolamine Ophthalmic Solution in Subjects With Dim Light Vision Disturbances","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2026.08.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}